Mobile Messaging for Colorectal Cancer Screening

(CoSMMO Trial)

This trial aims to develop and test a text message program that encourages patients to complete at-home screenings for colorectal cancer and ensures they receive follow-up care if needed. The trial will explore various message types, such as Autonomy Support Outreach, Impediments Support Outreach, Live Support Outreach, and Personalized Text Messages, to determine which ones most effectively engage patients and increase the completion rate of cancer screenings. Patients who have received an at-home colorectal cancer screening kit order and are at average risk, without a personal or family history of related issues, may be suitable for this trial. Participants should also have a mobile phone to receive text messages. As an unphased trial, this study provides an opportunity to contribute to innovative approaches in preventive healthcare.

The trial information does not specify whether you need to stop taking your current medications. It seems focused on testing a text message program for colorectal cancer screening, so it's unlikely that your medications would be affected.

Research has shown that using text messages to encourage colorectal cancer screening is generally safe and well-received. Text messaging boosts participation in screening programs without causing harm. For instance, studies have found that motivational text messages significantly increase the completion of fecal immunochemical tests (FIT), which check for colorectal cancer. Text messaging is also considered an acceptable way to involve patients in screening decisions.

Specific methods, such as personalized text messages and live support, have been used in past research without reported negative effects. Additionally, offering help to overcome screening obstacles has effectively increased participation without safety concerns.

Researchers are excited about this trial because it explores how different types of mobile messaging can impact colorectal cancer screening rates. Unlike traditional methods that rely on standard reminders, this trial tests personalized messages and support systems, including autonomy and live support, to see if they can better address individuals' concerns and motivations. By tailoring messages to address personal anxieties and leveraging different support mechanisms, the trial aims to uncover whether these innovative communication strategies can improve screening participation, potentially leading to earlier detection and better outcomes for patients.

This trial will evaluate various mobile messaging strategies to increase colorectal cancer screening rates. Studies have shown that sending messages to phones can boost the number of people getting screened for colorectal cancer. One study with veterans found that automated text reminders increased screening completion from 28% to 38% in just 90 days. Another study reported a 42% increase in screening rates in Alaska Native clinics due to text reminders. Additionally, reminders sent through the mail have effectively led to more completed tests. Personalized text messages, especially those tailored to encourage specific behaviors, have also been linked to higher participation in screenings. These findings suggest that mobile messaging is a promising way to encourage more people to complete their at-home colorectal cancer screenings. This trial will test different messaging approaches, including personalized and gain-framed messages, to determine the most effective strategy.⁴⁶⁷⁸⁹